CRX 527 is a TLR4 ligand and serves as an adjuvant for peptide cancer vaccines, enhancing anti-tumor immune responses. CRX 527 also induces hematopoietic stem cell (HSC) differentiation, increasing the proportion and number of LSK cells, and promotes their differentiation into macrophages. This activation bolsters immune defense and protects intestinal epithelium from radiation damage.
Molecular Weight:
1488.04
CAS Number:
[216014-14-1]
Formula:
C81H151N2O19P
Target:
TLR
T204958
* VAT and and shipping costs not included. Errors and price changes excepted
